Research institutes in Bengaluru, Hyderabad, New Delhi and Pune type these four clusters. “The consortium will track the emergence of viral variants correlated to epidemiological and clinical outcomes,” the media assertion from Bengaluru based mostly National Centre for Biological Sciences (NCBS), which is part of the consortium, mentioned.
The coalition goals to develop methods and capabilities to determine variants of concern earlier than they unfold broadly and trigger outbreaks. “This will help correlate with clinical symptoms and disease severity, potentially associated with emerging variants,” the workforce mentioned.
The initiative includes goal sampling methods based mostly on granular epidemiological and scientific information. It may also embrace intense environmental surveillance and superior computational methods to get correct information. It may also concentrate on constructing capabilities for real-time surveillance and epidemiology.
CSIR-Center for Cellular and Molecular Biology (CCMB), Hyderabad, will lead the consortium. Other companions embrace NCBS-TIFR, Institute for Stem Cell Science & Regenerative Medicine (InStem) and NIMHANS in Bengaluru, CSIR-Institute of Genomics and Integrative Biology in Delhi, Pune Knowledge Cluster, IISER and CSIR-National Chemical Laboratory in Pune. CCMB advisor Rakesh Mishra will lead the efforts.
CCMB director Vinay Nandicoori mentioned the much-needed collaboration will carry all strengths of all these institutes collectively in a structured style.
Bengaluru companion NCBS director Satyajit Mayor mentioned: “leveraging the capacity of each of the city clusters both in academic institutions and industry, is a much-needed effort at this time. This can help create a sustainable platform for genomic surveillance long after Covid, and for many other infectious diseases.”